Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to

Yang Yang1, Yingjian He1, Zhaoqing Fan2

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.

NPJ Breast Cancer
|July 24, 2023
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos